We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$31.9B
AUM Growth
+$3.19B
Cap. Flow
+$655M
Cap. Flow %
2.06%
Top 10 Hldgs %
37.2%
Holding
1,711
New
132
Increased
1,102
Reduced
353
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 36.43%
2 Communication Services 10.67%
3 Consumer Discretionary 9.33%
4 Healthcare 6.07%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLI icon
1326
Mueller Industries
MLI
$14.8B
$55K ﹤0.01%
1,088
-122
-10% -$5.6K
NVAX icon
1327
Novavax
NVAX
$1.32B
$54.4K ﹤0.01%
6,279
+22
+0.4% +$171
JOYY
1328
JOYY Inc
JOYY
$3.72B
$54.3K ﹤0.01%
927
-66
-7% -$3.63K
CRBG icon
1329
Corebridge Financial
CRBG
$15.1B
$53.8K ﹤0.01%
1,679
+495
+42% +$16.9K
FCPT icon
1330
Four Corners Property Trust
FCPT
$2.77B
$53.7K ﹤0.01%
2,201
+130
+6% +$3.36K
DQ
1331
Daqo New Energy
DQ
$1B
$53.6K ﹤0.01%
1,905
+206
+12% +$4.83K
DXC icon
1332
DXC Technology
DXC
$1.73B
$52.1K ﹤0.01%
3,824
+147
+4% +$2.09K
THO icon
1333
Thor Industries
THO
$4.14B
$51.7K ﹤0.01%
499
-64
-11% -$6.45K
TXG icon
1334
10x Genomics
TXG
$7.69B
$51.7K ﹤0.01%
4,423
+132
+3% +$1.72K
LENZ
1335
LENZ Therapeutics
LENZ
$152M
$51.4K ﹤0.01%
1,103
+16
+1% +$588
ARDX icon
1336
Ardelyx
ARDX
$1.01B
$51.3K ﹤0.01%
9,316
+74
+0.8% +$402
SNDX icon
1337
Syndax Pharmaceuticals
SNDX
$1.74B
$51.2K ﹤0.01%
3,330
+6
+0.2% +$79
XERS icon
1338
Xeris Biopharma Holdings
XERS
$1.57B
$50.8K ﹤0.01%
6,243
+56
+0.9% +$372
VMI icon
1339
Valmont Industries
VMI
$9.53B
$50K ﹤0.01%
129
-14
-10% -$5.09K
STOK icon
1340
Stoke Therapeutics
STOK
$2.12B
$49.8K ﹤0.01%
2,118
+9
+0.4% +$154
GMAB icon
1341
Genmab
GMAB
$19.2B
$49.7K ﹤0.01%
1,621
+1
+0.1% +$24
ZYME icon
1342
Zymeworks
ZYME
$1.8B
$49.6K ﹤0.01%
2,906
+214
+8% +$3.06K
G icon
1343
Genpact
G
$5.7B
$48.8K ﹤0.01%
+1,165
New +$51.2K
IVT icon
1344
InvenTrust Properties
IVT
$2.62B
$48.6K ﹤0.01%
1,699
+95
+6% +$2.69K
PK icon
1345
Park Hotels & Resorts
PK
$2.99B
$48.5K ﹤0.01%
4,380
+199
+5% +$2.24K
CSAN icon
1346
Cosan
CSAN
$2.53B
$48.3K ﹤0.01%
10,498
+384
+4% +$1.77K
NSA
1347
DELISTED
National Storage Affiliates Trust
NSA
$48.1K ﹤0.01%
1,592
+88
+6% +$2.75K
NEU icon
1348
NewMarket
NEU
$8.72B
$48K ﹤0.01%
58
-14
-19% -$10.8K
AMPH icon
1349
Amphastar Pharmaceuticals
AMPH
$852M
$47.9K ﹤0.01%
1,798
-23
-1% -$594
MKL icon
1350
Markel Group
MKL
$22.9B
$47.8K ﹤0.01%
25
+19
+317% +$37.2K

Similar funds

Mirae Asset Global Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Mirae Asset Global Investments held 1,711 positions worth $31.9B, up 11% from $28.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mirae Asset Global Investments's Q3 2025 filing shows 132 new, 1,102 increased, 353 reduced and 69 closed positions. Its largest new stake was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M. The largest sale was Vanguard S&P 500 ETF, an estimated $453M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Mirae Asset Global Investments's largest Q3 2025 buy was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M.
  • Mirae Asset Global Investments added most to NVIDIA in Q3 2025, an estimated $81.9M increase.
  • Mirae Asset Global Investments's biggest Q3 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $453M.
  • Mirae Asset Global Investments fully exited iShares S&P 100 ETF in Q3 2025, selling an estimated $58.9M.
  • Mirae Asset Global Investments's ten largest holdings make up 37% of its $31.9B portfolio in Q3 2025.
  • Mirae Asset Global Investments opened 132 new positions and closed 69 in Q3 2025.
  • Mirae Asset Global Investments's portfolio value rose 11% quarter-over-quarter to $31.9B.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.